Almonertinib-Induced Interstitial Lung Disease in an NSCLC Patient Harboring an EGFR Ex19del Mutation: A Case Report.

Gao X, He D, Yang H, Pang X, Liang L

Open source

DOI
10.1159/000550877
Published
2026 Jan-Dec
Container
Case reports in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000550877,
  title = {Almonertinib-Induced Interstitial Lung Disease in an NSCLC Patient Harboring an EGFR Ex19del Mutation: A Case Report.},
  author = {Gao X and He D and Yang H and Pang X and Liang L},
  year = {2026},
  journal = {Case reports in oncology},
  doi = {10.1159/000550877},
  url = {https://doi.org/10.1159/000550877}
}

RIS

TY  - JOUR
TI  - Almonertinib-Induced Interstitial Lung Disease in an NSCLC Patient Harboring an EGFR Ex19del Mutation: A Case Report.
AU  - Gao X
AU  - He D
AU  - Yang H
AU  - Pang X
AU  - Liang L
PY  - 2026
JO  - Case reports in oncology
DO  - 10.1159/000550877
UR  - https://doi.org/10.1159/000550877
ER  - 

APA

X, G., D, H., H, Y., X, P., & L, L. (2026). Almonertinib-Induced Interstitial Lung Disease in an NSCLC Patient Harboring an EGFR Ex19del Mutation: A Case Report.. Case reports in oncology. https://doi.org/10.1159/000550877

Source records